Risk factors for osteoporosis, falls and fractures in hereditary myopathies and sporadic inclusion body myositis — A cross sectional survey

作者: F. Danckworth , N. Karabul , A. Posa , F. Hanisch

DOI: 10.1016/J.YMGMR.2013.12.005

关键词:

摘要: Abstract Background The risk of osteoporosis is known in myopathies requiring long-term steroid treatment and Pompe disease, but not other hereditary or sporadic inclusion body myositis (sIBM). Methods Risk factors osteoporosis, laboratory parameters bone metabolism, frequency falls fractures, walking ability, pain were surveyed using questionnaires 89 patients with sIBM genetically confirmed facioscapulohumeral muscular dystrophy (FSHD), myotonic types 1 2 (DM1, DM2), limb girdle dystrophies (LGMD2A, LGMD2B, LGMD2I), MATR3 myopathy, oculopharyngeal (OPMD). Additionally metabolism determined. Results mean age at examination per disease group ranged from 32 years LGMD2A to 70 sIBM. Myopathies a higher degree impairment had (sIBM, LGMD2A, LGMD2B). At the time 3.4% history osteoporosis. 25-OH D3 level was decreased 20% (and 55% LGMDs), 57% them ambulatory. significantly lower than neurological disorders (p  Conclusion for reduced seems be increased wheelchair-bound myopathy also DM1 autosomal-recessive myopathies.

参考文章(41)
Deborah Gavin-Dreschnack, Jeffrey Harrow, Audrey Nelson, Shahbaz Ahmed, Shirley Fitzgerald, Aurora Sanchez-Anguiano, Fall-related fractures in persons with spinal cord impairment: a descriptive analysis. SCI nursing : a publication of the American Association of Spinal Cord Injury Nurses. ,vol. 20, pp. 30- 37 ,(2003)
C.M. Court-Brown, N. Clement, Four score years and ten: an analysis of the epidemiology of fractures in the very elderly. Injury-international Journal of The Care of The Injured. ,vol. 40, pp. 1111- 1114 ,(2009) , 10.1016/J.INJURY.2009.06.011
Erika Baum, Klaus M. Peters, The diagnosis and treatment of primary osteoporosis according to current guidelines. Deutsches Arzteblatt International. ,vol. 105, pp. 573- ,(2008) , 10.3238/ARZTEBL.2008.0573
Emma K. Stanmore, Jackie Oldham, Dawn A. Skelton, Terence O'Neill, Mark Pilling, A. John Campbell, Chris Todd, Risk factors for falls in adults with rheumatoid arthritis: A prospective study Arthritis Care and Research. ,vol. 65, pp. 1251- 1258 ,(2013) , 10.1002/ACR.21987
Linda E.M. van den Berg, Adrienne A. Zandbergen, Carine I. van Capelle, Juna M. de Vries, Wim C. Hop, Johanna M. van den Hout, Arnold J.J. Reuser, M. Carola Zillikens, Ans T. van der Ploeg, Low bone mass in Pompe disease. Muscular strength as a predictor of bone mineral density Bone. ,vol. 47, pp. 643- 649 ,(2010) , 10.1016/J.BONE.2010.06.021
Peyman Hadji, Silvia Klein, Holger Gothe, Bertram Häussler, Thomas Kless, Torsten Schmidt, Thomas Steinle, Frank Verheyen, Roland Linder, The epidemiology of osteoporosis--Bone Evaluation Study (BEST): an analysis of routine health insurance data. Deutsches Arzteblatt International. ,vol. 110, pp. 52- 57 ,(2013) , 10.3238/ARZTEBL.2013.0052
Leto Mailli, Dimitrios K. Filippiadis, Elias N. Brountzos, Efthymia Alexopoulou, Nikolaos Kelekis, Alexios Kelekis, Clinical Outcome and Safety of Multilevel Vertebroplasty: Clinical Experience and Results CardioVascular and Interventional Radiology. ,vol. 36, pp. 183- 191 ,(2013) , 10.1007/S00270-012-0379-Z
Kimmo I. Suokas, Maija Haanpää, Hannu Kautiainen, Bjarne Udd, Aki J. Hietaharju, Pain in patients with myotonic dystrophy type 2: A postal survey in finland Muscle & Nerve. ,vol. 45, pp. 70- 74 ,(2012) , 10.1002/MUS.22249
M. Fanin, C. Angelini, Muscle pathology in dysferlin deficiency Neuropathology and Applied Neurobiology. ,vol. 28, pp. 461- 470 ,(2002) , 10.1046/J.1365-2990.2002.00417.X